HPV: New Vaccine and New Issues

Thursday, March 13, 2008: 8:30 AM-10:15 AM
International Ballroom South
8:30 AM
D7a
Anal Human Papillomavirus Infection and Abnormal Cytology in Women with Genital Dysplasia
Ina U. Park, MD, MS, California Department of Public Health; James W. Ogilvie, MD, University of Minnesota; Lindsay Darrah, MD, University of Minnesota; Kristin E. Anderson, PhD, MPH, University of Minnesota; Zhong-ze Li, MS, University of Minnesota; Robert Madoff, MD, University of Minnesota; Levi Downs, MD, University of Minnesota
8:45 AM
D7b
HPV 6, 11, 16 and 18 seroprevalence in men in a clinic-based study
Eileen F. Dunne, MD, MPH, Centers for Disease Control and Prevention; Carrie M. Nielson, MPH, OHSU; Robin Harris, PhD, Arizona Cancer Center and Mel and Enid Zuckerman College of Publ; Lauri Markowitz, MD, Centers for Disease Control and Prevention; Anna Giuliano, PhD, H. Lee Moffitt Cancer Center and Research Institute; Michael Hagensee, MD, PhD, LSU Schoool of Medicine
9:00 AM
D7c
Making sense of HPV and Pap test results: What do women need and want to know? Findings from CDC qualitative research with women, ages 30-65 years
Allison L. Friedman, MS, Centers for Disease Control & Prevention; Hilda Shepeard, PhD, MBA, Centers for Disease Control & Prevention
9:15 AM
D7d
HPV Vaccination in Communities with High Rates of Cervical Cancer: A Survey of Caregivers of Adolescent Girls in North Carolina
Sami L. Gottlieb, MD, MSPH, CDC; Noel T. Brewer, PhD, UNC Gillings School of Global Public Health; Karen Ziarnowski, University of North Carolina, Chapel Hill; Nicole Liddon, PhD, CDC; Jennifer S. Smith, PhD, University of North Carolina, Chapel Hill; Lauri E. Markowitz, MD, CDC
9:30 AM
D7e
The HPV Vaccine: A Content Analysis of Online News Stories
Melissa A. Habel, MPH, Centers for Disease Control & Prevention; Nicole Liddon, Centers for Disease Control and Prevention; Jo Ellen Stryker, PhD, Emory Unviersity
See more of: Oral and Poster